Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent ...

The benefit of implantable cardioverter-defibrillators (ICDs) among elderly patients is controversial and may be attenuated by nonarrhythmic death. We examined the impact of age on device-delivered ...

The DANISH study (Danish Study to Assess the Efficacy of ICDs [Implantable Cardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) did not demonstrate an ...

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric ...

The Faraflex catheter [Image from Brad Sutton on LinkedIn] Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio. The Marlborough ...

The portable defibrillator monitor FC-1760 goes everywhere with color LCD monitor that allows ECG monitoring as required. Package is built more compact and lightweight, thereby allowing the nursing ...

Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, North Carolina, USA Correspondence to Dr James P ...

A new multi-society Appropriate Use Criteria (AUC) document focuses on cardiac implantable electronic devices (CIEDs), specifically implantable cardioverter-defibrillators (ICDs), cardiac ...

3 Golden Jubilee National Hospital, Queen Elizabeth University Hospital, Glasgow, Clydebank, UK Correspondence to Professor John J V McMurray, British Heart Foundation Cardiovascular Research Centre, ...